Search results (298)
« Back to PublicationsLung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.
Journal article
Li S. et al, (2026), Cell reports. Medicine
Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.
Journal article
Dorbutr T. et al, (2026), Scientific reports
The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection.
Journal article
Li S. et al, (2026), iScience, 29
Exploring the ethics of tuberculosis human challenge models.
Journal article
Rohrig A. et al, (2026), Journal of medical ethics, 52, 251 - 260
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Journal article
Stewart I. et al, (2026), EBioMedicine, 124
Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.
Journal article
Korompis M. et al, (2026), Frontiers in immunology, 17
Characterising Lung Mucosal and Systemic Immune Response in Human Following Inhalation of Attenuated Mycobacterium Bovis BCG Using Single Cell Sequencing
Conference paper
Li S. et al, (2026), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 212
Evaluation of 1st WHO anti-malaria reference reagent for competition ELISA harmonisation and development of ADAMSEL analytical platform.
Journal article
Khatri B. et al, (2025), Biologicals : journal of the International Association of Biological Standardization, 92
Acute Plasmodium yoelii 17XNL Infection During BCG Vaccination Limits T Cell Responses and Mycobacterial Growth Inhibition.
Journal article
Tangie E. et al, (2025), Immunology, 176, 373 - 384
MetE: a promising protective antigen for tuberculosis vaccine development
Journal article
Almujri SS. et al, (2025), Frontiers in Immunology, 16
Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States.
Journal article
Chen C. et al, (2025), Chest, 168, 33 - 42
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response
Journal article
Drennan PG. et al, (2025), The Lancet Microbe, 6, 101045 - 101045
Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics
Journal article
Roope LSJ. et al, (2025), Contemporary Clinical Trials Communications, 45, 101467 - 101467
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG
Journal article
Marshall JL. et al, (2025), Nature Communications, 16
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.
Journal article
Siegal EZ. et al, (2025), NPJ vaccines, 10